4/A: Chemed Corp Executive Brian C. Judkins Reports Stock Transactions
SEC Form 4/A Filing
Chemed Corp's VP and Chief Legal Officer, Brian C. Judkins, executed multiple transactions involving company stock and options on March 20, 2024, including the sale of 11,158 shares.
Summary
- Brian C. Judkins, VP and Chief Legal Officer of Chemed Corp, filed an amended Form 4 detailing changes in beneficial ownership.
- On March 20, 2024, Judkins acquired 5,825 shares of capital stock at $413.19 and 6,133 shares at $471.74 through option exercises.
- He also sold 11,158 shares of capital stock at a weighted average price of $645, with individual sales ranging from $642.00 to $649.00.
- Following these transactions, Judkins directly owns 1,533 shares of capital stock and holds options for 29,183 and 23,050 shares at exercise prices of $413.19 and $471.74 respectively.
- The filing amends a previous filing from the same date due to an administrative error.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't indicate any positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
- The reported transactions are typical for executives who receive stock options as part of their compensation.
- The vesting schedules for the options are also common, with annual installments over a few years.
Stakeholder Impact
- The transactions may have a minor impact on the stock price due to the volume of shares sold.
- The filing provides transparency to shareholders regarding executive stock transactions.
Key Dates
| Date | Description |
|---|---|
| 03/20/2024 | Date of the reported stock transactions and original filing. |
| 10/29/2020 | Commencement date for vesting of 5,825 stock options. |
| 10/29/2021 | Commencement date for vesting of 6,133 stock options. |
| 10/29/2024 | Expiration date for 5,825 stock options. |
| 10/29/2025 | Expiration date for 6,133 stock options. |
| 12/20/2024 | Date of signature on the amended filing. |
Keywords
Chemed Corp, stock transactions, insider trading, Form 4, stock options, Brian C. Judkins, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.